Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.57B |
| 2 |
Tesla
TSLA
|
+$1.06B |
| 3 |
Amazon
AMZN
|
+$597M |
| 4 |
Qualcomm
QCOM
|
+$374M |
| 5 |
AbbVie
ABBV
|
+$373M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.54B |
| 2 |
Johnson & Johnson
JNJ
|
+$561M |
| 3 |
UnitedHealth
UNH
|
+$353M |
| 4 |
Meta Platforms (Facebook)
META
|
+$345M |
| 5 |
Starbucks
SBUX
|
+$340M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.63% |
| 2 | Technology | 13.19% |
| 3 | Consumer Discretionary | 10.53% |
| 4 | Financials | 8.74% |
| 5 | Communication Services | 7.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
RLJ Lodging Trust
RLJ
$1.67B
| $6.28M | ﹤0.01% |
354,332
-115,142
| -25% | -$1.96M |
|
|
CSOD
1727
DELISTED
Cornerstone OnDemand, Inc.
CSOD
| $6.28M | ﹤0.01% |
107,200
-174,400
| -62% | -$10.1M |
|
1728
DXP Enterprises
DXPE
$3.12B
| $6.23M | ﹤0.01% |
156,400
+16,300
| +12% | +$608K |
|
1729
Fortive
FTV
$18.6B
| $6.22M | ﹤0.01% |
129,081
-331,425
| -72% | -$15M |
|
1730
ImmunityBio
IBRX
$8.02B
| $6.2M | ﹤0.01% |
1,634,925
+39,200
| +2% | +$66.7K |
|
1731
Raymond James Financial
RJF
$34.8B
| $6.18M | ﹤0.01% |
+103,613
| New | +$5.98M |
|
|
TWNK
1732
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
| $6.16M | ﹤0.01% |
423,500
-122,000
| -22% | -$1.66M |
|
1733
Arvinas
ARVN
$587M
| $6.13M | ﹤0.01% |
+149,200
| New | +$4.37M |
|
1734
CGI
GIB
$15.2B
| $6.12M | ﹤0.01% |
+73,158
| New | +$5.89M |
|
1735
MBIA
MBI
$264M
| $6.11M | ﹤0.01% |
656,992
+428,618
| +188% | +$4.08M |
|
1736
Option Care Health
OPCH
$3.59B
| $6.11M | ﹤0.01% |
409,339
+36,912
| +10% | +$499K |
|
|
AVID
1737
DELISTED
Avid Technology Inc
AVID
| $6.09M | ﹤0.01% |
710,267
+74,600
| +12% | +$549K |
|
1738
Hingham Institution for Saving
HIFS
$680M
| $6.08M | ﹤0.01% |
28,948
+1,648
| +6% | +$318K |
|
1739
Lakeland Industries
LAKE
$117M
| $6.04M | ﹤0.01% |
559,492
+34,400
| +7% | +$370K |
|
|
TSC
1740
DELISTED
TriState Capital Holdings, Inc.
TSC
| $6.03M | ﹤0.01% |
230,700
-7,100
| -3% | -$169K |
|
|
CMRX
1741
DELISTED
Chimerix, Inc.
CMRX
| $6M | ﹤0.01% |
2,954,136
+654,509
| +28% | +$1.21M |
|
1742
NorthWestern Energy
NWE
$4.42B
| $5.99M | ﹤0.01% |
83,504
-240,185
| -74% | -$17.3M |
|
1743
iShares China Large-Cap ETF
FXI
$4.16B
| $5.98M | ﹤0.01% |
137,100
-54,400
| -28% | -$2.27M |
|
1744
Titan Machinery
TITN
$429M
| $5.97M | ﹤0.01% |
403,900
+50,091
| +14% | +$780K |
|
1745
iShares Core 1-5 Year USD Bond ETF
ISTB
$5.13B
| $5.97M | ﹤0.01% |
118,400
+50,700
| +75% | +$2.55M |
|
1746
Kosmos Energy
KOS
$1.51B
| $5.94M | ﹤0.01% |
+1,042,638
| New | +$6.29M |
|
|
RUTH
1747
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
| $5.89M | ﹤0.01% |
270,728
-10,272
| -4% | -$226K |
|
1748
Gencor Industries
GENC
$264M
| $5.89M | ﹤0.01% |
504,686
+9,539
| +2% | +$115K |
|
|
SEAC
1749
DELISTED
Seachange International Inc
SEAC
| $5.88M | ﹤0.01% |
70,202
-879
| -1% | -$59.7K |
|
1750
Travelzoo
TZOO
$73.4M
| $5.87M | ﹤0.01% |
548,300
-10,700
| -2% | -$111K |
|
Similar funds
Jim Simons's Q4 2019 Portfolio in Review
As of Q4 2019, Jim Simons held 3,913 positions worth $130B, up 10% from $118B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Jim Simons's Q4 2019 filing shows 518 new, 1,836 increased, 1,085 reduced and 443 closed positions. Its largest new stake was Amazon: 6,745,100 shares worth $623M. The largest sale was Celgene Corp, an estimated $1.54B.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jim Simons's largest Q4 2019 buy was Amazon: 6,745,100 shares worth $623M.
- Jim Simons added most to Bristol-Myers Squibb in Q4 2019, an estimated $1.57B increase.
- Jim Simons's biggest Q4 2019 reduction was Johnson & Johnson, cutting an estimated $561M.
- Jim Simons fully exited Celgene Corp in Q4 2019, selling an estimated $1.54B.
- Jim Simons's ten largest holdings make up 13% of its $130B portfolio in Q4 2019.
- Jim Simons opened 518 new positions and closed 443 in Q4 2019.
- Jim Simons's portfolio value rose 10% quarter-over-quarter to $130B.
Based on Renaissance Technologies's 13F filing for Q4 2019, filed 13 Feb 2020.